📰 Recursion Pharmaceuticals News
Page 3 - Recursion Pharmaceuticals News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Recursion Pharmaceuticals. Real-time updates on events, politics, business and more.
April 25, 2024
The risk at these companies is above average, and they're sure to remain volatile. This volatility, however, includes explosively bullish potential.
April 25, 2024
The risk at these companies is above average, and they're sure to remain volatile. This volatility, however, includes explosively bullish potential.
April 24, 2024
“Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
April 24, 2024
Cramer recommends selling PBR, buying EPD, LNG, RXRX, and CASY. Criticisms of AVGO's licensing changes dismissed. PBR and CASY stocks rise.
April 23, 2024
The U.S. Department of Justice is closely monitoring AI competitors with shared board members.
April 23, 2024
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
April 21, 2024
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) Director Blake Borgeson sold 11,447 shares of the stock in a transaction on Tuesday, April 16th. The shares were sold at an average price of $7.66, for a total transaction of $87,684.02. Following the completion of the sale, the director now directly owns 7,229,861 shares in the […]
April 11, 2024
On Wednesday, Cathie Wood-led Ark Invest sold shares of Coinbase Global, Inc.
April 10, 2024
Thematic ETFs are an easy way to play a trend rather than trying to pick a winner.
April 10, 2024
Marketresearch.biz reports that the Generative AI in Pharma market size is expected to be worth around USD 2258.1 Mn by 2033 from USD 159.9 Mn in 2023, growing at a CAGR of 31.2% during the forecast period from 2024 to 2033.Overview of the Generative AI in Pharma MarketGenerative AI in pharma revolutionizes drug dis...